OraSure Technologies | OSUR - Ebit



金融业
股票价格
USD
资产
USD 379.17M
现金及等价物
USD 176.96M
销售成本
USD 15.43M
流动资产
USD 240.78M
流动负债
USD 44.08M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 313.32M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 266.4M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 30.31M
贸易债权人
USD 10.63M
应收帐款人
USD 22.2M


Ebit 更改 日
Agilent USD 353M 90M 2025-12
AngioDynamics USD -2.51M 5.41M 2025-09
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 941.3M 1.36B 2025-12
Bruker USD 10.2M 66.1M 2026-03
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 119.9M 44.08M 2026-03
Danaher USD 1.34B 158M 2026-03
Dentsply International USD 32M 506M 2026-03
Dexcom USD 255.3M 67.7M 2026-03
Illumina USD 239M 17M 2026-03
Integra LifeSciences USD 11.47M 54.54M 2026-03
Intuitive Surgical USD 859.7M 5.6M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Mesa Laboratories USD 4.45M 2.5M 2024-09
Mettler Toledo International USD 233.93M 118M 2026-03
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Quidel USD -27.4M 9.9M 2026-03
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
STAAR Surgical USD 17.4M 28.34M 2026-03
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Trinity Biotech USD -10.02M 8.31M 2024-12
Waters USD 148M 122.52M 2026-03